Sinopharm
1099.HK
#2008
Rank
HK$63.19 B
Marketcap
HK$20.25
Share price
-0.74%
Change (1 day)
6.72%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Market capitalization of Sinopharm (1099.HK)

Market cap: HK$63.19 Billion

As of November 2024 Sinopharm has a market cap of HK$63.19 Billion. This makes Sinopharm the world's 2008th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Sinopharm from 2009 to 2024

End of year Market Cap

Year Marketcap Change
2024HK$63.19 B-0.99%
2023HK$63.82 B2.82%
2022HK$62.07 B17.28%
2021HK$52.92 B-5.36%
2020HK$55.92 B-33.85%
2019HK$84.54 B-13.53%
2018HK$97.76 B4.58%
2017HK$93.48 B5.74%
2016HK$88.40 B2.73%
2015HK$86.05 B13.3%
2014HK$75.95 B32.92%
2013HK$57.14 B-1.92%
2012HK$58.26 B30.05%
2011HK$44.80 B-27%
2010HK$61.36 B-1.63%
2009HK$62.38 B

End of Day market cap according to different sources

On Nov 9th, 2024 the market cap of Sinopharm was reported to be:

HK$63.19 Billion
by Yahoo Finance info icon info icon
HK$63.19 Billion
by CompaniesMarketCap info icon info icon